Acid Reflux News and Research RSS Feed - Acid Reflux News and Research

Acid reflux disease is a condition that often results when a valve located at the end of the esophagus malfunctions. When this valve relaxes inappropriately, it may allow stomach acid to splash up and irritate the lining of the esophagus, creating the sensation called heartburn, and other uncomfortable symptoms. Frequent, persistent heartburn is the primary symptom associated with acid reflux disease or GERD.
Inflammatory response prompted by secretion of cytokines causes acid reflux damage in GERD patients

Inflammatory response prompted by secretion of cytokines causes acid reflux damage in GERD patients

The "acid" in "acid reflux" may not be the direct cause of damage to the esophagus as previously suspected, according to researchers at UT Southwestern Medical Center and Dallas VA Medical Center. [More]
Laparoscopic surgery offers safe alternative to acid reflux drugs

Laparoscopic surgery offers safe alternative to acid reflux drugs

A new analysis indicates that death rates and the need for additional operations following laparoscopic surgery for gastro-oesophageal reflux disease are very low. [More]
Study finds no evidence of lactase deficiency specific to autistic children with GI symptoms

Study finds no evidence of lactase deficiency specific to autistic children with GI symptoms

Children with autism have no unique pattern of abnormal results on endoscopy or other tests for gastrointestinal (GI) disorders, compared to non-autistic children with GI symptoms, reports a study in the Journal of Pediatric Gastroenterology and Nutrition, official journal of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. [More]
Olympus introduces EZDilate balloon dilator for improved control in endoscopic balloon dilation procedures

Olympus introduces EZDilate balloon dilator for improved control in endoscopic balloon dilation procedures

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today its new 510(k) cleared EZDilate multi-stage endoscopic balloon dilator for improved precision and control in endoscopic balloon dilation procedures. [More]
Stony Brook Medicine expert shares tips to minimize heartburn during holiday season

Stony Brook Medicine expert shares tips to minimize heartburn during holiday season

The holiday season is upon us and most days and nights will be filled with delicious festivities! However, with millions of Americans suffering from heartburn, fear may set in when anticipating these celebrations. [More]
EndoGastric Solutions announces assignment of relative value units for new CPT code covering TIF procedure

EndoGastric Solutions announces assignment of relative value units for new CPT code covering TIF procedure

EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), today announced the Federal Register has posted coding and payment information specific to the new Current Procedural Terminology (CPT)® code covering the Transoral Incisionless Fundoplication (TIF®) procedure. [More]
Common heartburn, acid reflux drugs may increase risk for developing kidney disease

Common heartburn, acid reflux drugs may increase risk for developing kidney disease

Certain medications commonly used to treat heartburn and acid reflux may have damaging effects on the kidneys, according to two studies that will be presented at ASN Kidney Week 2015 November 3–8 at the San Diego Convention Center in San Diego, CA. The drugs, proton pump inhibitors (PPIs), are among the top 10 class of prescribed medications in the United States. [More]
AGS releases updated, expanded Beers Criteria to improve medication use in older adults

AGS releases updated, expanded Beers Criteria to improve medication use in older adults

The American Geriatrics Society today released its second updated and expanded Beers Criteria--lists of potentially inappropriate medications for older adults who are not receiving hospice or palliative care, and one of the most frequently cited reference tools in the field of geriatrics. [More]
CU research suggests safe, lower-cost way to treat upper gastrointestinal tract problems in children

CU research suggests safe, lower-cost way to treat upper gastrointestinal tract problems in children

Physicians at the University of Colorado School of Medicine on the Anschutz Medical Campus have published research that suggests a safe and lower-cost way to diagnose and treat problems in the upper gastrointestinal tract of children. [More]
Substantial pharmacogenetic information available on cardiovascular drugs

Substantial pharmacogenetic information available on cardiovascular drugs

There is a wealth of published information describing interactions between drugs used to treat cardiovascular disease and the genetic variations that can affect how patients respond to them. But few heart specialists make routine use of this potentially life-saving data. [More]
Incidence of esophageal cancer linked to GERD rises six-fold in recent decades

Incidence of esophageal cancer linked to GERD rises six-fold in recent decades

Esophageal cancer is one of the fastest-growing and deadliest cancers in the U.S. According to the American Cancer Society, an estimated 17,000 new cases of esophageal cancer will be diagnosed in 2015. Incidence of adenocarcinoma, a type of esophageal cancer linked to GERD (gastroesophageal reflux disease) has risen six-fold in recent decades. [More]
New research could transform treatments for patients with Barrett's Oesophagus

New research could transform treatments for patients with Barrett's Oesophagus

New research from the University of Warwick and University Hospitals Coventry and Warwickshire NHS Trust could transform treatments and diagnosis for a common digestive condition which affects thousands of patients. [More]
Somna Therapeutics receives FDA clearance to market REZA BAND UES Assist Device in U.S.

Somna Therapeutics receives FDA clearance to market REZA BAND UES Assist Device in U.S.

Somna Therapeutics today announced that the U.S. Food and Drug Administration cleared the REZA BAND UES Assist Device for marketing in the U.S. The REZA BAND is a ground-breaking, new, externally-worn, non-medication, non-surgical medical device designed to reduce symptoms of laryngopharyngeal reflux (LPR) by stopping regurgitation of stomach contents through the upper esophageal sphincter (UES). [More]
St. John Hospital first in Michigan to offer new alternative treatment for acid reflux disease

St. John Hospital first in Michigan to offer new alternative treatment for acid reflux disease

St. John Hospital is among the first in the state and the only site in southeast Michigan to offer a new alternative treatment for patients with acid reflux disease. [More]
Childhood obesity linked to higher risk of developing oesophageal cancer in later life

Childhood obesity linked to higher risk of developing oesophageal cancer in later life

Overweight children may be at higher risk of oesophageal (gullet) cancer when they grow up than their slimmer friends, according to research published this week in the British Journal of Cancer. [More]
Oral budesonide suspension offers hope for pediatric patients with EoE

Oral budesonide suspension offers hope for pediatric patients with EoE

A new formulation of oral budesonide suspension, a steroid-based treatment, is safe and effective in treating pediatric patients with eosinophilic esophagitis (EoE), according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association. [More]
Antacid medicines improve overall survival in patients with head and neck cancer

Antacid medicines improve overall survival in patients with head and neck cancer

Patients with head and neck cancer who used antacid medicines to control acid reflux had better overall survival, according to a new study from the University of Michigan Comprehensive Cancer Center. [More]
New Mayo Clinic study shows impact of long-term use of proton pump inhibitors

New Mayo Clinic study shows impact of long-term use of proton pump inhibitors

Before reaching for that daily antacid, you might consider what it's doing to the trillions of bugs living in your gut. A new Mayo Clinic study in the open access journal Microbiome shows that people who regularly take proton pump inhibitors (PPIs) have less diversity among their gut bacteria, putting them at increased risk for infections like clostridium difficile and pneumonia, in addition to vitamin deficiencies and bone fractures. [More]
Study shows that obese children may mistake asthma symptoms, overuse rescue medications

Study shows that obese children may mistake asthma symptoms, overuse rescue medications

New research shows obese children with asthma may mistake symptoms of breathlessness for loss of asthma control leading to high and unnecessary use of rescue medications. The study was published online in the Journal of Allergy and Clinical Immunology, the official scientific journal of the American Association of Allergy, Asthma and Immunology. [More]
Insulin can protect cells of pancreas from acute pancreatitis

Insulin can protect cells of pancreas from acute pancreatitis

Scientists from The University of Manchester have discovered that insulin can protect the cells of the pancreas from acute pancreatitis - a disease for which there is currently no treatment. [More]
Advertisement
Advertisement